ARCHIVES

ImClone Founding CEO Samuel Waksal Charged With Securities Fraud, Conspiracy, Perjury

This article is from The Cancer Letter archive.

Vol. 28 No. 24 | June 14, 2002

Download PDF Visit The Full Archive

Related Articles

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010

NIH Priority To Pay 4,000 Grants, Send Summary Statements

February 2, 1996

Three Bomb Threats At NIH In One Week result In Evacuations, Investigations

August 2, 1996

Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO

May 24, 1996

Exercisers May Have Higher Breast Cancer Survival

October 27, 2006

ACS Says NCI Needs $1.1 Billion, Cites Progress In Prevention, Control

April 29, 1977